Data presented in this report together with our recent study14 provide evidence that BTG3 acts to regulate at least two proproliferation pathways frequently deregulated in cancers: the MAPK (mitogen-activated protein kinase) and the AKT pathways. This evidence concerns the gene WNK2 and cancer.